Law firms are actively seeking people who have been harmed, injured or have developed acute pancreatitis from taking the diabetes medicine called Januvia.

There may be a class action lawsuit forming with possible cash settlement claims for diabetes patients who were given Januvia.

What is Januvia?

Januvia is an orally administered diabetes medicine that can help to control blood sugar levels. It works by regulating the levels of insulin the body produces after eating.

Januvia are in tablets and contain a chemical compound called sitagliptin phosphate, an orally-active inhibitor of the dipeptidyl peptidase-4 (DPP-4) enzyme.

Januvia is only for people with type 2 diabetes. It is sometimes used in combination with other diabetes medications, but is not for treating type 1 diabetes.

FDA Warning for Januvia

The FDA issued a warning to healthcare providers about diabetes drugs Januvia and Janumet, manufactured by Merck & Co., Inc. These drugs are in the class known as sitaglipins, and are designed to help treat patients with type-2 diabetes and type-2 diabetes mellitus.

Post-marketing surveillance reveals that the drugs may be associated with acute pancreatitis after reports of 88 patients experiencing that condition between October 2006 and February 2009.